EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Pathogenesis of nontypeable Haemophilus influenzae infections in chronic suppurative lung disease

Grigorios Chatziparasidis iD, Ahmad Kantar iD, Keith Grimwood

Pediatric Pulmonology · 2023-07 · 58 (7) · 1849-1860

DOI: 10.1002/ppul.26446 ↗

At a glance

Journal article in Pediatric Pulmonology, published online on 2023-05-03. Written by Grigorios Chatziparasidis and 2 co-authors. Institution: Paediatric Respiratory Unit, IASO Hospital, Larissa, Thessaly, Greece. Major MEDLINE topics: Haemophilus Infections, Lung Diseases. Cited 18 times so far (Crossref); 137 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The respiratory tract antimicrobial defense system is a multilayered defense mechanism that relies upon mucociliary clearance and components of both the innate and adaptive immune systems to protect the lungs from inhaled or aspirated microorganisms. One of these potential pathogens, nontypeable Haemophilus influenzae ( NTHi ), adopts several, multifaceted redundant strategies to successfully colonize the lower airways and establish a persistent infection. NTHi can impair mucociliary clearance, express multiple multifunctional adhesins for various cell types within the respiratory tract and evade host defenses by surviving within and between cells, forming biofilms, increasing antigenic drift, secreting proteases and antioxidants, and by host‐pathogen cross‐talk, impair macrophage and neutrophil function. NTHi is recognized as an important pathogen in several chronic lower respiratory disorders, such as protracted bacterial bronchitis, bronchiectasis, cystic fibrosis, and primary ciliary dyskinesia. The persistence of NTHi in human airways, including its capacity to form biofilms, results in chronic infection and inflammation, which can ultimately injure airway wall structures. The complex nature of the molecular pathogenetic mechanisms employed by NTHi is incompletely understood but improved understanding of its pathobiology will be important for developing effective therapies and vaccines, especially given the marked genetic heterogeneity of NTHi and its possession of phase‐variable genes. Currently, no vaccine candidates are ready for large phase III clinical trials.

Subjects

MeSH terms (MEDLINE)

Haemophilus InfectionsLung DiseasesHumansHaemophilus influenzaeLungBiofilmsSuppuration

Author keywords

lung damagenontypeable Haemophilus influenzaerespiratory infection

Authors and institutions

  • Paediatric Respiratory Unit, IASO Hospital, Larissa, Thessaly, Greece.
  • Faculty of Nursing, Thessaly University, Larissa, Greece.
  • Pediatric Asthma and Cough Centre, Instituti Ospedalieri Bergamaschi, Bergamo, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • School of Medicine and Dentistry, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • Departments of Infectious Disease and Paediatrics, Gold Coast Health, Southport, Queensland, Australia.

ORCID profiles: Grigorios Chatziparasidis, Ahmad Kantar

Cite

APA

Chatziparasidis, G., Kantar, A., & Grimwood, K. (2023). Pathogenesis of nontypeable Haemophilus influenzae infections in chronic suppurative lung disease. Pediatric Pulmonology, 58(7), 1849-1860. https://doi.org/10.1002/ppul.26446

Vancouver

Chatziparasidis G, Kantar A, Grimwood K. Pathogenesis of nontypeable Haemophilus influenzae infections in chronic suppurative lung disease. Pediatric Pulmonology. 2023;58(7):1849-1860. doi:10.1002/ppul.26446

BibTeX
@article{Chatziparasidis2023,
  author = {Chatziparasidis, Grigorios and Kantar, Ahmad and Grimwood, Keith},
  title = {Pathogenesis of nontypeable Haemophilus influenzae infections in chronic suppurative lung disease},
  journal = {Pediatric Pulmonology},
  year = {2023},
  volume = {58},
  number = {7},
  pages = {1849--1860},
  doi = {10.1002/ppul.26446}
}
Start for free →